CTI BIOPHARMA CORP Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cti Biopharma Corp quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Cti Biopharma Corp Return On Equity for the quarter ending March 31, 2023 was 426 %.
  • Cti Biopharma Corp annual Return On Equity for 2022 was 550 %.
  • Cti Biopharma Corp annual Return On Equity for 2021 was -299 %, a 137% decline from 2020.
  • Cti Biopharma Corp annual Return On Equity for 2020 was -126 %, a 2.4% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 550 +849 Jan 1, 2022 Dec 31, 2022
2021 -299 -173 -137% Jan 1, 2021 Dec 31, 2021
2020 -126 +3.1 +2.4% Jan 1, 2020 Dec 31, 2020
2019 -129 -81.6 -170% Jan 1, 2019 Dec 31, 2019
2018 -47.9 +175 +78.5% Jan 1, 2018 Dec 31, 2018
2017 -223 -36.6 -19.6% Jan 1, 2017 Dec 31, 2017
2016 -186 +2.4K +92.8% Jan 1, 2016 Dec 31, 2016
2015 -2.58K -2.14K -484% Jan 1, 2015 Dec 31, 2015
2014 -442 -152 -52.4% Jan 1, 2014 Dec 31, 2014
2013 -290 +1.71K +85.5% Jan 1, 2013 Dec 31, 2013
2012 -2K Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.